News from generic pharmaceutical association A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

Oct 24, 2016, 01:40 ET Jeffrey K. Francer Joins GPhA as Senior Vice President and General Counsel

Today the Generic Pharmaceutical Association (GPhA) announced that Jeffrey K. Francer will join the association as Senior Vice President and General...


Oct 19, 2016, 12:40 ET Generic Drugs Continue to Deliver Billions in Savings to the U.S. Healthcare System, New Report Finds

Annual savings from generic prescription drugs increased 328 percent from 2005-2016, according to the new 2016 Generic Drug Savings and Access in the ...


Sep 16, 2016, 12:36 ET GPhA CEO to hold Conference Call on Drug Costs, Increasing Generic Competition

Chip Davis, President and CEO, Generic Pharmaceutical Association (GPhA) will hold a news conference Monday to outline his organization's response to ...


Dec 08, 2015, 10:43 ET GPhA Names Chris Bowlin as Senior Vice President, Government Affairs

The Generic Pharmaceutical Association (GPhA) today announced the appointment of Chris Bowlin as Senior Vice President of Government Affairs. "Chris...


Jul 22, 2015, 11:50 ET Generic Pharmaceutical Association Selects Chester "Chip" Davis, Jr. as President and CEO

Today, the Generic Pharmaceutical Association (GPhA), named Chester "Chip" Davis, Jr. President and CEO. Mr. Davis assumes the role effective August...


Apr 16, 2015, 12:17 ET GPhA Launches Biosimilars Council, New Industry Group Will Educate and Advocate for Patient Access to Safe, Affordable Lifesaving Medicines

The Generic Pharmaceutical Association (GPhA) is pleased to announce today's launch of the Biosimilars Council, a division of GPhA. "Following...


Dec 02, 2014, 10:00 ET GPhA Hires Terry Bazyluk for Senior Communications Post

The Generic Pharmaceutical Association (GPhA) announced that it has named Terry Bazyluk as Vice President for Communications, effective December 1,...


Sep 24, 2014, 10:40 ET Statement by Ralph G. Neas, President and CEO, GPhA, Regarding the 30th Anniversary of the Hatch-Waxman Act

"When President Ronald Reagan signed the Drug Price Competition and Patent Term Restoration Act 30 years ago today, few could imagine how the law...


Sep 10, 2014, 10:01 ET Generic Pharmaceutical Savings Reach Highest-Ever Watermark of $239 Billion in 2013

The Generic Pharmaceutical Association (GPhA) today released a report showing that generic drugs saved the United States health system $239 billion...


Jan 29, 2014, 12:31 ET Statement by Ralph G. Neas, President and CEO, Generic Pharmaceutical Association, Regarding the State of the Union Address

"In last night's State of the Union address, President Obama said, 'Today in America… [a]rural doctor gave a young child the first prescription to...


Jan 06, 2014, 05:44 ET Centers for Medicare and Medicaid Services (CMS) Report Shows Slower Growth in Health Spending, Generic Medicines Critical to Cost Control, GPhA/IMS Health Data Affirms

Today, the Centers for Medicare and Medicaid Services (CMS) issued findings that show slower growth in health spending since the implementation of...


Dec 19, 2013, 03:08 ET Generic Pharmaceutical Savings Reach $217 Billion in 2012

The Generic Pharmaceutical Association (GPhA) today released the fifth annual report, Generic Drug Savings in the U.S., showing that the use of...


Jul 09, 2013, 03:11 ET New Study Shows Pharmaceutical Patent Settlements Netted $25.5 Billion in Savings for U.S. Health System

Generic pharmaceuticals launched prior to patent expiration due to a patent settlement helped the U.S. health system save $25.5 billion from...


Mar 25, 2013, 12:42 ET Former Clinton Deputy Solicitor General sheds light on flaws in Federal Trade Commission's case in FTC v. Actavis Inc.

On the day the U.S. Supreme Court hears oral arguments in FTC v. Actavis, a case that challenges the rights of brand-name and generic drug...


Jan 29, 2013, 11:21 ET Statement from Ralph G. Neas, President and CEO, Generic Pharmaceutical Association, on the Front Page New York Times Story Regarding the Pre-emptive Strikes of Amgen/Genentech to Restrict Access to Affordable and Safe Biosimilars

oday's story shines a light on what essentially is a pre-emptive strike by Amgen and Genentech designed to choke the flow of safe and affordable...


Aug 02, 2012, 10:00 ET New Study Finds Use of Generic Prescription Drugs Saved Consumers and the U.S. Health Care System $1 Trillion over Past Decade

The Generic Pharmaceutical Association (GPhA) today released an independently conducted analysis showing that the savings to consumers and the U.S....


Apr 19, 2012, 01:30 ET GPhA Enlists IMS Health to Further Address Drug Shortage Crisis

The Generic Pharmaceutical Association (GPhA) today announced that it has selected IMS Health to serve as the Independent Third Party (ITP) in the...


Sep 07, 2011, 07:00 ET GPhA Taps Ralph G. Neas as New President and Chief Executive Officer

The Generic Pharmaceutical Association (GPhA), which represents the world's leading generic drug manufacturers and suppliers, today announced that it ...


May 04, 2010, 01:35 ET GPhA Announces that Kathleen Jaeger Will Leave Trade Association

The Generic Pharmaceutical Association today released the following statement by Paul Bisaro, GPhA Chairman of the Board and President and CEO of...